...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Extracranial-intracranial bypass for the treatment of cavernous sinus aneurysms.
【24h】

Extracranial-intracranial bypass for the treatment of cavernous sinus aneurysms.

机译:颅外-颅内旁路治疗海绵窦动脉瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

The optimal management of symptomatic cavernous sinus aneurysms remains controversial. Carotid occlusion is a simple procedure, but carries an ongoing risk of early and late stroke. Cerebral revascularisation is technically demanding and carries a risk of morbidity and mortality of around 10%. Eight patients treated with an extracranial-intracranial vascular bypass graft over a period of 44 months for symptomatic cavernous sinus aneurysms are reviewed. At a mean follow-up of 20 months, seven patients (87.5%) had an excellent outcome (Glasgow Outcome Score 5) while one patient suffered a perioperative stroke. In only one case, where the radial artery had been used, the graft became occluded. The results of this series seem to indicate that cerebral revascularisation is an effective treatment for patients with symptomatic cavernous sinus aneurysms.
机译:有症状的海绵窦动脉瘤的最佳治疗仍存在争议。颈动脉闭塞是一个简单的程序,但仍存在中风早期和晚期的风险。脑血运重建在技术上是苛刻的,并且具有发病率和死亡率约10%的风险。回顾了在44个月内接受颅外-颅内血管搭桥术治疗的8例有症状的海绵窦动脉瘤的患者。平均随访20个月,有7例(87.5%)的患者预后良好(格拉斯哥预后评分5),而1例患者围手术期卒中。仅在使用the动脉的一种情况下,移植物被阻塞。该系列结果似乎表明,脑血管重建术是有症状的海绵窦动脉瘤患者的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号